source
- Roche KRAS drug succeeds in head-to-head lung cancer studyThe Phase 3 trial compared Roche’s divarasib with treatments sold by Amgen and Bristol Myers in patients with non-small cell lung cancer.BioPharma Dive · 28d ago↗ source
- STAT+: Roche drug sets new standard for KRAS-driven lung cancerBiotech's bull market, Vertex's gene therapy expansion, and more news from The ReadoutSTAT · 28d ago↗ source
- Vertex's sickle cell therapy approved for kids; United Therapeutics buys startup🧬 Vertex’s sickle cell gene therapy approved for kids: Casgevy may now be used to treat either sickle cell disease with recurrent vaso-occlusive crises or transfusion-dependent β-thalassemia patie…Endpoints · 28d ago↗ source